Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Neoplasm Metastasis 8 Recurrence 5 Endometrial Neoplasms 4 Tuberous Sclerosis 3 Neoplasms 3 Glioma 3 Glioblastoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Kidney Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thymus Neoplasms 1 Seizures 1

Interventions

pembrolizumab 4 Magnetic Resonance Spectroscopy 3 lenvatinib 2 Specimen Handling 2 Nivolumab 2 Carboplatin 2 regorafenib 1 gallium 68 PSMA-11 1 enfortumab vedotin 1 amivantamab 1 Tablets 1 Surveys and Questionnaires 1 Standard of Care 1 Radiosurgery 1 Pemetrexed 1 Ipilimumab 1 Imatinib Mesylate 1 Glutamate Carboxypeptidase II 1 Etoposide 1 Epirubicin 1 Endoscopic Mucosal Resection 1 Cyclophosphamide 1 Combined Modality Therapy 1 Cisplatin 1 CTLA-4 Antigen 1 Blood Specimen Collection 1 BMS-906024 1 68Ga-DKFZ-PSMA-11 1 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡